Home
Clinical Resources Search
PQI: Androgen Deprivation Therapy with Relugolix (Orgovyx®)

Androgen Deprivation Therapy with Relugolix (Orgovyx®)

Download PQI pdf 0.12MB

Last Updated: February 12, 2024

By: Collin Dempsey PharmD, BCPS

About this PQI

The purpose of this PQI is to provide awareness of an oral androgen deprivation therapy (ADT) option for patients undergoing treatment for prostate cancer and to discuss counseling, monitoring parameters, and patient management strategies to maximize medication adherence and improve patient outcomes.

More About This PQI

PQI in Action Articles:

Relugolix_orgovyx_ADT pdf 1.52MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Prostate Cancer Orgovyx RELUGOLIX

PQI

Frequently Searched

Supported by

Androgen Deprivation Therapy with Relugolix (Orgovyx®)

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC

PQI: Bone Health and the Cancer Patient

PQI: Encorafenib (Braftovi®) + Cetuximab (Erbitux®) + mFOLFOX6 for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI in Action: Fruquintinib (Fruzaqla®)

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

PQI in Action: Proactive Symptom Management in Myelofibrosis

PQI in Action: Sonidegib (Odomzo®) Patient Management

S8 Bonus Eps 2: Inside ASCO 2025

S8 E15: Supporting Survivors at Work

S8 E14: Advancing Geriatric Oncology

S8 Ep 13: Supporting Patients Through Financial Assistance

Readiness Tracker

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Treatment Support Kit: Tivozanib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

PQI: Use of Rucaparib (Rubraca®) and Indications

PQI: Talazoparib (Talzenna®) and Enzalutamide (Xtandi®) in HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer

PQI: Radium Ra 223 Dichloride (Xofigo®) Management

PQI: Olaparib (Lynparza®) Clinical Management

PQI in Action: Androgen Deprivation Therapy with Relugolix (Orgovyx®)

PQI in Action: Androgen Deprivation Therapy with Relugolix (Orgovyx®)

PQI in Action: Fruquintinib (Fruzaqla®)

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI: Encorafenib (Braftovi®) and Binimetinib (Mektovi®) for the Management of NSCLC

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2